leap-015: lenvatinib pembrolizumab mfolfox6 in advanced/met gastroesophageal adenocarcinoma
Published 2 years ago • 176 plays • Length 2:44Download video MP4
Download video MP3
Similar videos
-
2:41
leap-011: exploring first-line pembrolizumab lenvatinib for advanced urothelial carcinoma
-
1:35
fight: bemarituzumab mfolfox6 in first-line advanced gastric cancer
-
1:06
leap-011: first-line pembrolizumab plus lenvatinib for uc
-
3:03
promising results from the gastric cancer cohort of leap-005
-
10:54
asco gi: adding lenvatinib to pembrolizumab in patients with advanced gastric cancer
-
4:35
keynote-062: pembrolizumab vs. chemo in 1l advanced gastric cancer
-
2:23
pembrolizumab plus chemotherapy for esophageal cancer: keynote-590
-
3:01
genomic landscape of late-stage gastric cancer treated with pembrolizumab
-
1:21
dr. shah on the rationale for the keynote-590 trial in esophageal carcinoma
-
2:21
lba41 - leap-005: phase ii study of lenvatinib plus pembrolizumab
-
3:15
pembrolizumab demonstrates promise in patients with pretreated metastatic gastric cancer
-
0:52
immunotherapy treatment options gastric and esophogeal cancers
-
2:09
keynote-240: pembrolizumab in advanced hcc
-
1:54
pembrolizumab in advanced gastric cancer treatment
-
1:15
treating mesothelioma with checkpoint inhibitors
-
5:00
surgical advances in in gastric and gej cancer
-
2:06
lenvatinib plus pembro for arcc - update on the clear study
-
30:31
gastroesophageal cancer: current positioning of immunotherapy
-
2:11
pembrolizumab vs. chemo in first-line mcrc